Encompass Health (EHC) EVP uses 6,990 shares to cover tax obligations

Rhea-AI Filing Summary

Encompass Health Corp executive John Patrick Darby reported a tax-related share disposition. On February 23, 2026, he disposed of 6,990 shares of Encompass Health common stock at a price of $106.15 per share to cover tax withholding obligations tied to vesting restricted stock.

After this tax-withholding transaction, Darby directly owned 84,363 shares of Encompass Health common stock. The filing describes the event as shares withheld or surrendered to pay tax liabilities, rather than an open-market sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Darby John Patrick

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Gen Counsel & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/23/2026		F		6,990(1)	D	$106.15	84,363	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	Patrick Darby	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Encompass Health (EHC) report for John Patrick Darby?

Encompass Health reported that executive John Patrick Darby disposed of 6,990 common shares. The shares were withheld or surrendered to satisfy tax withholding obligations arising from the vesting of related restricted stock, rather than being sold in an open-market transaction.

Was the Encompass Health (EHC) Form 4 transaction an open-market sale?

No, the Form 4 transaction was not an open-market sale. The 6,990 shares were withheld or surrendered to cover Darby’s tax withholding obligations upon vesting of restricted stock, according to the filing’s footnote, rather than being voluntarily sold on the market.

How many Encompass Health (EHC) shares does John Patrick Darby own after the Form 4 event?

After the reported tax-withholding disposition, John Patrick Darby directly owns 84,363 Encompass Health common shares. This post-transaction figure reflects his remaining direct holdings following the surrender of 6,990 shares for tax obligations related to restricted stock vesting.

What was the price used for the Encompass Health (EHC) tax-withholding share disposition?

The filing reports a transaction price of $106.15 per Encompass Health common share. This price was used in the calculation for the 6,990 shares withheld or surrendered to satisfy John Patrick Darby’s tax withholding obligations tied to restricted stock vesting.

What role does John Patrick Darby hold at Encompass Health (EHC)?

John Patrick Darby serves as Executive Vice President, General Counsel and Secretary at Encompass Health. His Form 4 filing reflects a tax-withholding share disposition related to vesting restricted stock, not a discretionary purchase or sale of the company’s common stock.